Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

5:16 PM ET 8-K
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Financial Results

Cheetah Net Supply Chain Service reported Q3 2026 revenue of $3.56 million, an 883% increase year-over-year driven by its international trading business acquisition. Despite the revenue growth, the company reported a net loss from continuing operations of $2.55 million, primarily due to a $2.78 million non-cash loss from the change in fair value of acquisition-related contingent consideration.

Term
Q3 2026

“The third quarter of 2026 marked an important step forward in the execution of our business diversification strategy. Following the acquisition of Super International Trading Limited in May, our international trading business demonstrated encouraging momentum, generating approximately $3.56 million in revenue during the quarter.”

Tony Liu, Cheetah’s Chairman and CEO

“Looking ahead, we remain committed to disciplined capital allocation, prudent financial management, and the pursuit of strategic opportunities that complement our existing capabilities.”

Tony Liu, Cheetah’s Chairman and CEO
5:15 PM ET 10-Q
Financial Results CaliberCos Inc. CWD

CaliberCos Q3 2026 Results: Net Loss of $5.03M, Loss Widens

CaliberCos Inc. reported a net loss of $18.0 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period. Total assets increased significantly to $178.9 million from $135.4 million at year-end 2025, primarily driven by the consolidation of new investment funds and real estate assets.

Key figure
Net loss $5.03M
5:15 PM ET 10-Q
Financial Results Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $77.8M

Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.

Key figure
Net income $77.8M
5:15 PM ET 8-K
Financial Results Where Food Comes From, Inc. WFCF

Where Food Comes From Financial Results

Where Food Comes From reported Q3 2026 total revenue of $7.3M, up 4% year-over-year, driven by 6% growth in its core verification and certification business. Operating income grew 68% to $1.0M as gross margins expanded to 42.1% due to cost-reduction initiatives and service bundling. The company also returned $268,000 to shareholders through stock buybacks during the quarter.

Term
Q3 2026

“We are pleased to report strong third quarter financial results highlighted by 6% growth in our core verification and certification business that is benefitting from resurgent demand for beef-related services and growing momentum in other service offerings.”

John Saunders, Chairman and CEO

“Our profit metrics also showed continued strength with gross margins rising by 380 basis points to 42.1% and operating income growing 68% to $1.0 million from $600,000 a year ago – both reflecting the positive impact of our ongoing cost down initiatives in conjunction with accelerating revenue.”

John Saunders, Chairman and CEO
5:15 PM ET 10-Q
Financial Results Research Alliance Corp IV RACD

Research Alliance Corp IV Q3 2026 Results: Net Income $379K

Research Alliance Corp IV reported a net income of $379,042 for the quarter ended September 30, 2026, primarily driven by $534,815 in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $75,534,815 currently held in trust for its Class A ordinary shares.

Key figure
Net income $379K
5:14 PM ET 10-Q
Financial Results CIM Opportunity Zone Fund, L.P.

CIM Opportunity Zone Fund Q3 2026 Results: Net Income $7.87M, Up 42.0% YoY

CIM Opportunity Zone Fund, L.P. reported a net loss of $44.8 million for the nine months ended September 30, 2026, compared to a net income of $110.8 million in the prior year period. The decline was primarily driven by the absence of a $117.4 million realized gain on a lease investment recorded in 2025 and increased operating and interest expenses.

Key figure
Net income $7.87M · +42.0% YoY
5:13 PM ET 10-Q
Financial Results DataMeds AI, Inc. MEDS

DataMeds AI Q3 2026 Results: Turns Profitable, Net Income $10.6M

DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a net income of $10.5 million for the quarter ended September 30, 2026, primarily driven by a $19.1 million gain on debt extinguishment. However, the company experienced a significant decline in nine-month revenues from $21.7 million in 2025 to $6.0 million in 2026, resulting in a year-to-date net loss of $15.6 million.

Key figure
Net income $10.6M
5:12 PM ET 10-Q
Financial Results GRI Bio, Inc. GRI

GRI Bio Q3 2026 Results: Net Loss of $1.51M, Loss Narrows

GRI Bio, Inc. reported a net loss of $5.15 million for the nine months ended September 30, 2026, a significant reduction from the $9.30 million loss in the prior year period, primarily due to lower research and development expenses. The company strengthened its liquidity through an ATM offering, ending the period with $9.47 million in cash and cash equivalents. GRI Bio remains a clinical-stage biopharmaceutical company with an accumulated deficit of $56.84 million and no significant revenue.

Key figure
Net loss $1.51M
5:11 PM ET 10-Q
Financial Results Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals Q3 2026 Results: Net Loss of $183M, Loss Widens

Processa Pharmaceuticals reported a significant net loss of $189.8 million for the nine months ended September 30, 2026, primarily driven by a $178.0 million charge for acquired in-process research and development following the acquisition of Vidya Therapeutics. The company significantly strengthened its liquidity position during the period, ending with $180.2 million in cash and cash equivalents following a $200.0 million private placement financing.

Key figure
Net loss $183M
5:11 PM ET 10-Q
Financial Results Valor Energy Inc VAI

Valor Energy Q2 2026 Results: Net Loss of $8.05M, Loss Widens

Valor Energy Inc reported a significant net loss of $40.8 million for the six months ended September 30, 2026, primarily driven by a $34.1 million non-cash charge for the excess of warrant fair value over offering proceeds. Despite the loss, the company strengthened its cash position to $12.5 million following a $10.2 million net inflow from a Units Private Placement.

Key figure
Net loss $8.05M
5:09 PM ET 10-Q
Financial Results Astrotech Corp ASTC

Astrotech Q1 2026 Results: Net Loss of $2.95M, Loss Narrows

Astrotech reported a net loss of $2.9 million for the quarter ended September 30, 2026, compared to a $3.5 million loss in the prior year. Revenue decreased slightly to $274 thousand, while the company maintained a cash position of $5.6 million following an 'at-the-market' share issuance that raised $467 thousand.

Key figure
Net loss $2.95M
5:08 PM ET 10-Q
Financial Results Kairos Pharma, LTD. KAPA

Kairos Pharma Q3 2026 Results: Net Loss of $1.98M, Loss Widens

Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.

Key figure
Net loss $1.98M
5:07 PM ET 10-Q
Financial Results Cerenome, Inc. CNSY ▶ Call

Cerenome Q3 2026 Results: Net Loss of $8.66M, Loss Widens

Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.

Key figure
Net loss $8.66M
5:07 PM ET 8-K
Financial Results Beasley Broadcast Group Inc BBGI

Beasley Broadcast Group Financial Results

Beasley Broadcast Group reported third quarter 2026 net revenue of $42.8 million, a 16.1% decrease year-over-year driven by weakness in national and local agency advertising. The company reported a net loss of $12.1 million for the quarter but highlighted improved digital operating margins of 32% and the completion of asset sales generating over $10 million in proceeds subsequent to quarter-end.

Term
Q3 2026
5:06 PM ET 8-K
Financial Results Health In Tech, Inc. HIT

Health In Tech Financial Results

Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.

Term
Q3 2026

“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”

Sanjay Shrestha, Chief Executive Officer of Health In Tech
5:04 PM ET 10-Q
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Q3 2026 Results: Net Loss of $2.55M, Loss Widens

Cheetah Net Supply Chain Service Inc. reported a significant increase in revenue to $4.52 million for the nine months ended September 30, 2026, compared to $1.20 million in the prior year. Despite this growth, the company realized a net loss of $3.09 million, driven by high operating expenses and a $2.78 million loss related to the change in fair value of an acquisition-related contingent consideration asset.

Key figure
Net loss $2.55M
5:02 PM ET 10-Q
Financial Results Healthcare Triangle, Inc. HCTI

Healthcare Triangle Q3 2026 Results: Net Loss of $2.53M, Loss Widens

Healthcare Triangle, Inc. reported a significant revenue increase to $28.2 million for the nine months ended September 30, 2026, compared to $10.8 million in the prior year, driven by business expansion. However, the company continues to operate at a loss, with a net loss from operations of $9.7 million for the period and a total asset base that grew to $72.7 million following substantial increases in intangible assets.

Key figure
Net loss $2.53M
5:02 PM ET 10-Q
Financial Results Fly-E Group, Inc. FLYE

Fly-E Group Q2 2026 Results: Net Loss of $1.74M, Loss Narrows

Fly-E Group, Inc. reported a significant decline in revenue to $5.34 million for the six months ended September 30, 2026, compared to $9.24 million in the prior year period. The company's net loss widened to $5.68 million for the same period, driven by decreased gross profit and high general and administrative expenses, raising concerns about its ability to continue as a going concern.

Key figure
Net loss $1.74M
5:02 PM ET 10-Q
Financial Results Presidio Property Trust, Inc. SQFT

Presidio Property Trust Q3 2026 Results: Net Loss of $531K, Loss Narrows

Presidio Property Trust reported a decrease in total revenue to $10.57 million for the nine months ended September 30, 2026, compared to $12.70 million in the prior year period. The company experienced a significant reduction in total assets from $122.1 million at year-end 2025 to $86.3 million, primarily driven by a decrease in real estate assets held for investment.

Key figure
Net loss $531K
5:02 PM ET 10-Q
Financial Results Scientific Industries Inc SCND

Scientific Industries Q3 2026 Results: Net Income $470K, Down 88.2% YoY

Scientific Industries reported a net loss of $2.35 million for the nine months ended September 30, 2026, compared to a net income of $0.69 million in the prior year period. While revenues increased to $4.05 million from $3.43 million, the prior year's profitability was primarily driven by a larger gain on the disposition of discontinued operations.

Key figure
Net income $470K · -88.2% YoY
5:01 PM ET 10-Q
Financial Results Mobiquity Technologies, Inc. MOBQ

Mobiquity Technologies Q3 2026 Results: Net Loss of $3.8M, Loss Widens

Mobiquity Technologies reported a significant revenue increase to $334,896 for the nine months ended September 30, 2026, compared to $160,795 in the prior year. However, net loss widened to $8.6 million due to higher general and administrative expenses, resulting in a total stockholders' deficit of $221,189.

Key figure
Net loss $3.8M
5:01 PM ET 10-Q
Financial Results Positron Corp POSC

Positron Q3 2026 Results: Net Loss of $972K, Loss Narrows

Positron Corp filed its Form 10-Q for the quarterly period ended September 30, 2026, detailing its financial performance and operational progress in the molecular imaging industry. The report highlights the company's focus on its PET imaging systems and the development of its radiopharmaceutical business segments.

Key figure
Net loss $972K
5:01 PM ET 10-Q
Financial Results Calidi Biotherapeutics, Inc. CLDI

Calidi Biotherapeutics Q3 2026 Results: Net Loss of $3.65M, Loss Narrows

Calidi Biotherapeutics reported a net loss of $11.9 million for the nine months ended September 30, 2026, compared to a $16.0 million loss in the prior year period. The company maintained a cash balance of $3.9 million as of September 30, 2026, and completed a 1-for-16 reverse stock split in July 2026 to adjust its capital structure.

Key figure
Net loss $3.65M
5:01 PM ET 10-Q
Financial Results EQT Private Equity Co LLC

EQT Private Equity Co Q3 2026 Results: Net Income $48.7M, Up 75.1% YoY

EQT Private Equity Company LLC reported total investments at fair value of $997.7 million as of September 30, 2026, representing a significant increase from $602.9 million at the end of 2025. The company maintains a diverse share structure across multiple classes and reported $165.6 million in cash and cash equivalents to support its ongoing private equity acquisition strategy.

Key figure
Net income $48.7M · +75.1% YoY
5:01 PM ET 10-Q
Financial Results Stardust Power Inc. SDST

Stardust Power Q3 2026 Results: Net Loss of $2.77M, Loss Narrows

Stardust Power Inc. reported total assets of $13.4 million and total liabilities of $15.4 million as of September 30, 2026, resulting in a stockholders' deficit. The company faces substantial doubt regarding its ability to continue as a going concern following its delisting from Nasdaq and transition to the Pink Limited Market.

Key figure
Net loss $2.77M
5:01 PM ET 10-K
Financial Results Guru App Factory Corp GAFC

Guru App Factory FY 2026 Results: Net Loss of $59.4K, Loss Widens

Guru App Factory Corp reported a decline in revenue from $94,500 in 2025 to $52,000 in 2026, primarily due to the non-recurrence of a large software development order. The company's net loss widened to $59,440, and its independent auditor issued a going concern warning due to a working capital deficit and accumulated deficit of $126,863.

Key figure
Net loss $59.4K
5:01 PM ET 10-Q
Financial Results Highview Merger Corp. HVMC

Highview Merger Q3 2026 Results: Net Income $1.81M, Up 82.9% YoY

Highview Merger Corp. reported a net income of $5.37 million for the nine months ended September 30, 2026, primarily driven by $6.24 million in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $239.85 million currently held in trust for potential redemptions.

Key figure
Net income $1.81M · +82.9% YoY
5:01 PM ET 10-Q
Financial Results EQT Infrastructure Co LLC

EQT Infrastructure Co Q3 2026 Results: Net Income $41.5M

EQT Infrastructure Company LLC reported total investments at fair value of $886.6 million as of September 30, 2026, a significant increase from zero at the end of 2025 following its initial offering in February 2026. The company maintains a complex share structure with over 44 million shares outstanding across various classes, primarily focused on acquiring and managing portfolio companies through joint ventures.

Key figure
Net income $41.5M
5:01 PM ET 10-Q
Financial Results Twelve Seas Investment Co III TWLV

Twelve Seas Investment Co III Q3 2026 Results: Turns Profitable, Net Income $1.46M

Twelve Seas Investment Company III is a shell company that completed its IPO on December 15, 2025, raising $172.5 million held in trust. As of September 30, 2026, the company has 17,745,000 Class A and 5,692,500 Class B ordinary shares outstanding and is seeking a business combination within a 24-month window ending December 15, 2027.

Key figure
Net income $1.46M
5:01 PM ET 8-K
Financial Results Beyond Air, Inc. XAIR

Beyond Air Financial Results

Beyond Air reported record quarterly revenue of $2.3 million for the period ended September 30, 2026, representing 28% year-over-year growth. The company reaffirmed its revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 while awaiting FDA approval for its second-generation LungFit PH system.

Term
Q2 2027

“Building on the commercial momentum we are generating with our first-generation LungFit PH system, we believe our second-generation system has the potential to substantially expand our market opportunity and accelerate growth, pending FDA approval.”

Robert Goodman, Chief Executive Officer of Beyond Air

“We remain encouraged by our active and productive discussions with the FDA and the progress we are making toward completing the remaining steps in the review process for the second-generation LungFit PH system.”

Robert Goodman, Chief Executive Officer of Beyond Air

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.